Creating Value by Overcoming Treatment Barriers View previous quarters - Today Latest News View all press releases 05.13.26 Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Read More 05.12.26 Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree Read More 05.06.26 Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET Read More Events View all events Upcoming Events There are no scheduled events at this time. Past Events 05.14.26 8:00 AM EDT Q1 2026 Aquestive Therapeutics, Inc. Earnings Conference Call 03.10.26 8:25 AM EDT Citizens Life Sciences Conference Presentations View all presentations Corporate Presentation – February 2026 Anaphylm™ (dibutepinephrine) Sublingual Film Complete Response Letter Supplemental Material 1.1 MB Anaphylm Pre-NDA Meeting Supplemental Material 525.4 KB
05.13.26 Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Read More
05.06.26 Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET Read More
